Yarrow Bioscience, Inc. (YARW) stock
YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30105% above fair value
$14.35+0.14 (+0.99%)
Close on Nov 18, 2026Market cap $38.31MP/E –Yield –
Yarrow Bioscience price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Yarrow Bioscience's price to sales ratio was 21.2× on Nov 11, 2026, against 16.0× a year earlier. Over the last 5 years it ranged from 6.7× to 102.1×, with a median of 32.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 21.2× | −2.9 |
| 2025 | Dec 31, 2025 | 24.1× | −76.1 |
| 2024 | Dec 31, 2024 | 100.2× | +78.5 |
| 2023 | Dec 29, 2023 | 21.8× | +10.1 |
| 2022 | Dec 30, 2022 | 11.7× | +0.7 |
| 2021 | Dec 31, 2021 | 11.0× | −4.7 |
| 2020 | Dec 31, 2020 | 15.7× | −345.5 |
| 2019 | Dec 31, 2019 | 361.3× | +354.1 |
| 2018 | Dec 31, 2018 | 7.1× | – |
See a number that looks wrong?